We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer's disease (AD) and AD-related neurodegenerative disorders (ADRD) that are rapidly impacting ...
On the stairs up to Alzheimer’s Research UK’s state-of-the-art Drug Discovery Institute (DDI), in University College London’s Cruciform Building, there is a plaque on the wall dedicated to ...